APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nystatin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nystatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchNystatin Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Nystatin Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Nystatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nystatin Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Nystatin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Nystatin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nystatin include 3B Scientific, BeiJing Hwrk Chemicals, Beijing NuoqiYa Biotechnology, BEST-REAGENT, BOC Sciences, Fishfa Biogenics, HBCChem, J & K SCIENTIFIC and LGM Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nystatin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nystatin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nystatin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nystatin market size, projected growth trends, production technologies, key applications, and end-use industries.

Nystatin Segment by Company

3B Scientific

BeiJing Hwrk Chemicals

Beijing NuoqiYa Biotechnology

BEST-REAGENT

BOC Sciences

Fishfa Biogenics

HBCChem

J & K SCIENTIFIC

LGM Pharma

Pure Chemistry Scientific

Toronto Research Chemicals

Waterstone Technology

XiaoGan ShenYuan ChemPharm

Olon S.p.A

Guangzhou Tosun Pharmaceutical

Pfizer

Concord Biotech

BrightGene Bio-Medical Technology

Antibiotice SA

Shanghai Minbiotech

Zhejiang Huida Biotech

Centrient Pharmaceuticals

Nystatin Segment by Type

USP Grade

Research Grade

Others

Nystatin Segment by Application

Skin

Oral Cavity

Others

Nystatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nystatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nystatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nystatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nystatin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nystatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nystatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nystatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nystatin Industry Trends Table 2. Nystatin Industry Drivers Table 3. Nystatin Industry Opportunities and Challenges Table 4. Nystatin Industry Restraints Table 5. Global Nystatin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nystatin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nystatin Sales by Manufacturers (t) & (2021-2026) Table 8. Global Nystatin Sales Market Share by Manufacturers Table 9. Global Nystatin Average Sales Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Nystatin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nystatin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nystatin Manufacturers, Product Type & Application Table 13. Global Nystatin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nystatin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of USP Grade Table 17. Major Manufacturers of Research Grade Table 18. Major Manufacturers of Others Table 19. Global Nystatin Sales by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Nystatin Sales by Type (2021-2026) & (t) Table 21. Global Nystatin Sales by Type (2027-2032) & (t) Table 22. Global Nystatin Sales Market Share by Type (2021-2026) Table 23. Global Nystatin Sales Market Share by Type (2027-2032) Table 24. Global Nystatin Revenue by Type 2021 VS 2025 VS 2032 (t) Table 25. Global Nystatin Revenue by Type (2021-2026) & (t) Table 26. Global Nystatin Revenue by Type (2027-2032) & (t) Table 27. Global Nystatin Revenue Market Share by Type (2021-2026) Table 28. Global Nystatin Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Skin Table 30. Major Manufacturers of Oral Cavity Table 31. Major Manufacturers of Others Table 32. Global Nystatin Sales by Application 2021 VS 2025 VS 2032 (t) Table 33. Global Nystatin Sales by Application (2021-2026) & (t) Table 34. Global Nystatin Sales by Application (2027-2032) & (t) Table 35. Global Nystatin Sales Market Share by Application (2021-2026) Table 36. Global Nystatin Sales Market Share by Application (2027-2032) Table 37. Global Nystatin Revenue by Application 2021 VS 2025 VS 2032 (t) Table 38. Global Nystatin Revenue by Application (2021-2026) & (t) Table 39. Global Nystatin Revenue by Application (2027-2032) & (t) Table 40. Global Nystatin Revenue Market Share by Application (2021-2026) Table 41. Global Nystatin Revenue Market Share by Application (2027-2032) Table 42. Global Nystatin Sales by Region: 2021 VS 2025 VS 2032 (t) Table 43. Global Nystatin Sales by Region (2021-2026) & (t) Table 44. Global Nystatin Sales Market Share by Region (2021-2026) Table 45. Global Nystatin Sales Forecasted by Region (2027-2032) & (t) Table 46. Global Nystatin Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Nystatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 48. North America Nystatin Sales by Country (2021-2026) & (t) Table 49. North America Nystatin Sales by Country (2027-2032) & (t) Table 50. Europe Nystatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 51. Europe Nystatin Sales by Country (2021-2026) & (t) Table 52. Europe Nystatin Sales by Country (2027-2032) & (t) Table 53. Asia Pacific Nystatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 54. Asia Pacific Nystatin Sales by Country (2021-2026) & (t) Table 55. Asia Pacific Nystatin Sales by Country (2027-2032) & (t) Table 56. South America, Middle East and Africa Nystatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 57. South America, Middle East and Africa Nystatin Sales by Country (2021-2026) & (t) Table 58. South America, Middle East and Africa Nystatin Sales by Country (2027-2032) & (t) Table 59. Global Nystatin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Nystatin Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Nystatin Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Nystatin Revenue Market Share by Region (2021-2026) Table 63. Global Nystatin Revenue Market Share by Region (2027-2032) Table 64. 3B Scientific Company Information Table 65. 3B Scientific Business Overview Table 66. 3B Scientific Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. 3B Scientific Nystatin Product Portfolio Table 68. 3B Scientific Recent Development Table 69. BeiJing Hwrk Chemicals Company Information Table 70. BeiJing Hwrk Chemicals Business Overview Table 71. BeiJing Hwrk Chemicals Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. BeiJing Hwrk Chemicals Nystatin Product Portfolio Table 73. BeiJing Hwrk Chemicals Recent Development Table 74. Beijing NuoqiYa Biotechnology Company Information Table 75. Beijing NuoqiYa Biotechnology Business Overview Table 76. Beijing NuoqiYa Biotechnology Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Beijing NuoqiYa Biotechnology Nystatin Product Portfolio Table 78. Beijing NuoqiYa Biotechnology Recent Development Table 79. BEST-REAGENT Company Information Table 80. BEST-REAGENT Business Overview Table 81. BEST-REAGENT Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. BEST-REAGENT Nystatin Product Portfolio Table 83. BEST-REAGENT Recent Development Table 84. BOC Sciences Company Information Table 85. BOC Sciences Business Overview Table 86. BOC Sciences Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. BOC Sciences Nystatin Product Portfolio Table 88. BOC Sciences Recent Development Table 89. Fishfa Biogenics Company Information Table 90. Fishfa Biogenics Business Overview Table 91. Fishfa Biogenics Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Fishfa Biogenics Nystatin Product Portfolio Table 93. Fishfa Biogenics Recent Development Table 94. HBCChem Company Information Table 95. HBCChem Business Overview Table 96. HBCChem Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. HBCChem Nystatin Product Portfolio Table 98. HBCChem Recent Development Table 99. J & K SCIENTIFIC Company Information Table 100. J & K SCIENTIFIC Business Overview Table 101. J & K SCIENTIFIC Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. J & K SCIENTIFIC Nystatin Product Portfolio Table 103. J & K SCIENTIFIC Recent Development Table 104. LGM Pharma Company Information Table 105. LGM Pharma Business Overview Table 106. LGM Pharma Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. LGM Pharma Nystatin Product Portfolio Table 108. LGM Pharma Recent Development Table 109. Pure Chemistry Scientific Company Information Table 110. Pure Chemistry Scientific Business Overview Table 111. Pure Chemistry Scientific Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Pure Chemistry Scientific Nystatin Product Portfolio Table 113. Pure Chemistry Scientific Recent Development Table 114. Toronto Research Chemicals Company Information Table 115. Toronto Research Chemicals Business Overview Table 116. Toronto Research Chemicals Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Toronto Research Chemicals Nystatin Product Portfolio Table 118. Toronto Research Chemicals Recent Development Table 119. Waterstone Technology Company Information Table 120. Waterstone Technology Business Overview Table 121. Waterstone Technology Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Waterstone Technology Nystatin Product Portfolio Table 123. Waterstone Technology Recent Development Table 124. XiaoGan ShenYuan ChemPharm Company Information Table 125. XiaoGan ShenYuan ChemPharm Business Overview Table 126. XiaoGan ShenYuan ChemPharm Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. XiaoGan ShenYuan ChemPharm Nystatin Product Portfolio Table 128. XiaoGan ShenYuan ChemPharm Recent Development Table 129. Olon S.p.A Company Information Table 130. Olon S.p.A Business Overview Table 131. Olon S.p.A Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Olon S.p.A Nystatin Product Portfolio Table 133. Olon S.p.A Recent Development Table 134. Guangzhou Tosun Pharmaceutical Company Information Table 135. Guangzhou Tosun Pharmaceutical Business Overview Table 136. Guangzhou Tosun Pharmaceutical Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Guangzhou Tosun Pharmaceutical Nystatin Product Portfolio Table 138. Guangzhou Tosun Pharmaceutical Recent Development Table 139. Pfizer Company Information Table 140. Pfizer Business Overview Table 141. Pfizer Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Pfizer Nystatin Product Portfolio Table 143. Pfizer Recent Development Table 144. Concord Biotech Company Information Table 145. Concord Biotech Business Overview Table 146. Concord Biotech Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Concord Biotech Nystatin Product Portfolio Table 148. Concord Biotech Recent Development Table 149. BrightGene Bio-Medical Technology Company Information Table 150. BrightGene Bio-Medical Technology Business Overview Table 151. BrightGene Bio-Medical Technology Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. BrightGene Bio-Medical Technology Nystatin Product Portfolio Table 153. BrightGene Bio-Medical Technology Recent Development Table 154. Antibiotice SA Company Information Table 155. Antibiotice SA Business Overview Table 156. Antibiotice SA Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Antibiotice SA Nystatin Product Portfolio Table 158. Antibiotice SA Recent Development Table 159. Shanghai Minbiotech Company Information Table 160. Shanghai Minbiotech Business Overview Table 161. Shanghai Minbiotech Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Shanghai Minbiotech Nystatin Product Portfolio Table 163. Shanghai Minbiotech Recent Development Table 164. Zhejiang Huida Biotech Company Information Table 165. Zhejiang Huida Biotech Business Overview Table 166. Zhejiang Huida Biotech Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Zhejiang Huida Biotech Nystatin Product Portfolio Table 168. Zhejiang Huida Biotech Recent Development Table 169. Centrient Pharmaceuticals Company Information Table 170. Centrient Pharmaceuticals Business Overview Table 171. Centrient Pharmaceuticals Nystatin Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Centrient Pharmaceuticals Nystatin Product Portfolio Table 173. Centrient Pharmaceuticals Recent Development Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Nystatin Distributors List Table 177. Nystatin Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Nystatin Product Image Figure 2. Global Nystatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nystatin Market Size (2021-2032) & (US$ Million) Figure 4. Global Nystatin Sales (2021-2032) & (t) Figure 5. Global Nystatin Average Price (USD/t) & (2021-2032) Figure 6. Global Top 5 and 10 Nystatin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. USP Grade Image Figure 9. Research Grade Image Figure 10. Others Image Figure 11. Global Nystatin Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Nystatin Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Nystatin Sales Market Share by Type (2021-2032) Figure 14. Global Nystatin Revenue by Type (2021 VS 2025 VS 2032) & (t) Figure 15. Global Nystatin Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Nystatin Revenue Market Share by Type (2021-2032) Figure 17. Skin Image Figure 18. Oral Cavity Image Figure 19. Others Image Figure 20. Global Nystatin Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 21. Global Nystatin Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Nystatin Sales Market Share by Application (2021-2032) Figure 23. Global Nystatin Revenue by Application (2021 VS 2025 VS 2032) & (t) Figure 24. Global Nystatin Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Nystatin Revenue Market Share by Application (2021-2032) Figure 26. North America Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 27. North America Nystatin Sales Market Share by Country (2021-2032) Figure 28. U.S. Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 29. Canada Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 30. Mexico Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 31. Europe Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 32. Europe Nystatin Sales Market Share by Country (2021-2032) Figure 33. Germany Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 34. France Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 35. U.K. Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 36. Italy Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 37. Netherlands Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 38. Asia Pacific Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 39. Asia Pacific Nystatin Sales Market Share by Country (2021-2032) Figure 40. China Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 41. Japan Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 42. South Korea Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 43. Southeast Asia Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 44. India Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 45. Australia Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 46. South America, Middle East and Africa Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 47. South America, Middle East and Africa Nystatin Sales Market Share by Country (2021-2032) Figure 48. Brazil Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 49. South Africa Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 50. Saudi Arabia Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 51. Turkey Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 52. Argentina Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 53. UAE Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 54. Egypt Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 55. Chile Nystatin Sales and Growth Rate (2021-2032) & (t) Figure 56. Global Nystatin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Nystatin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Nystatin Revenue (2021-2032) & (US$ Million) Figure 59. North America Nystatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Nystatin Revenue (2021-2032) & (US$ Million) Figure 61. Europe Nystatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Nystatin Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Nystatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Nystatin Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Nystatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Nystatin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Nystatin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • USP Grade
  • Research Grade
  • Others
Applications
  • Skin
  • Oral Cavity
  • Others
Companies covered
  • 3B Scientific
  • BeiJing Hwrk Chemicals
  • Beijing NuoqiYa Biotechnology
  • BEST-REAGENT
  • BOC Sciences
  • Fishfa Biogenics
  • HBCChem
  • J & K SCIENTIFIC
  • LGM Pharma
  • Pure Chemistry Scientific
  • Toronto Research Chemicals
  • Waterstone Technology
  • XiaoGan ShenYuan ChemPharm
  • Olon S.p.A
  • Guangzhou Tosun Pharmaceutical
  • Pfizer
  • Concord Biotech
  • BrightGene Bio-Medical Technology
  • Antibiotice SA
  • Shanghai Minbiotech
  • Zhejiang Huida Biotech
  • Centrient Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nystatin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nystatin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nystatin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nystatin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nystatin Market Dynamics
  1. 2.1 Nystatin Industry Trends
  2. 2.2 Nystatin Industry Drivers
  3. 2.3 Nystatin Industry Opportunities and Challenges
  4. 2.4 Nystatin Industry Restraints
3 Nystatin Market by Manufacturers
  1. 3.1 Global Nystatin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nystatin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nystatin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nystatin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nystatin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nystatin Manufacturers, Product Type & Application
  7. 3.7 Global Nystatin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nystatin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nystatin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nystatin Tier 1, Tier 2, and Tier 3
4 Nystatin Market by Type
  1. 4.1 Nystatin Type Introduction
  2. 4.1.1 USP Grade
  3. 4.1.2 Research Grade
  4. 4.1.3 Others
  5. 4.2 Global Nystatin Sales by Type
  6. 4.2.1 Global Nystatin Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nystatin Sales by Type (2021-2032)
  8. 4.2.3 Global Nystatin Sales Market Share by Type (2021-2032)
  9. 4.3 Global Nystatin Revenue by Type
  10. 4.3.1 Global Nystatin Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nystatin Revenue by Type (2021-2032)
  12. 4.3.3 Global Nystatin Revenue Market Share by Type (2021-2032)
5 Nystatin Market by Application
  1. 5.1 Nystatin Application Introduction
  2. 5.1.1 Skin
  3. 5.1.2 Oral Cavity
  4. 5.1.3 Others
  5. 5.2 Global Nystatin Sales by Application
  6. 5.2.1 Global Nystatin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nystatin Sales by Application (2021-2032)
  8. 5.2.3 Global Nystatin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Nystatin Revenue by Application
  10. 5.3.1 Global Nystatin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nystatin Revenue by Application (2021-2032)
  12. 5.3.3 Global Nystatin Revenue Market Share by Application (2021-2032)
6 Global Nystatin Sales by Region
  1. 6.1 Global Nystatin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nystatin Sales by Region (2021-2032)
  3. 6.2.1 Global Nystatin Sales by Region (2021-2026)
  4. 6.2.2 Global Nystatin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nystatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nystatin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nystatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nystatin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nystatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nystatin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nystatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nystatin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nystatin Revenue by Region
  1. 7.1 Global Nystatin Revenue by Region
  2. 7.1.1 Global Nystatin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nystatin Revenue by Region (2021-2026)
  4. 7.1.3 Global Nystatin Revenue by Region (2027-2032)
  5. 7.1.4 Global Nystatin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nystatin Revenue (2021-2032)
  8. 7.2.2 North America Nystatin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nystatin Revenue (2021-2032)
  11. 7.3.2 Europe Nystatin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nystatin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nystatin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nystatin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nystatin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 3B Scientific
  2. 8.1.1 3B Scientific Company Information
  3. 8.1.2 3B Scientific Business Overview
  4. 8.1.3 3B Scientific Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 3B Scientific Nystatin Product Portfolio
  6. 8.1.5 3B Scientific Recent Developments
  7. 8.2 BeiJing Hwrk Chemicals
  8. 8.2.1 BeiJing Hwrk Chemicals Company Information
  9. 8.2.2 BeiJing Hwrk Chemicals Business Overview
  10. 8.2.3 BeiJing Hwrk Chemicals Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BeiJing Hwrk Chemicals Nystatin Product Portfolio
  12. 8.2.5 BeiJing Hwrk Chemicals Recent Developments
  13. 8.3 Beijing NuoqiYa Biotechnology
  14. 8.3.1 Beijing NuoqiYa Biotechnology Company Information
  15. 8.3.2 Beijing NuoqiYa Biotechnology Business Overview
  16. 8.3.3 Beijing NuoqiYa Biotechnology Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beijing NuoqiYa Biotechnology Nystatin Product Portfolio
  18. 8.3.5 Beijing NuoqiYa Biotechnology Recent Developments
  19. 8.4 BEST-REAGENT
  20. 8.4.1 BEST-REAGENT Company Information
  21. 8.4.2 BEST-REAGENT Business Overview
  22. 8.4.3 BEST-REAGENT Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BEST-REAGENT Nystatin Product Portfolio
  24. 8.4.5 BEST-REAGENT Recent Developments
  25. 8.5 BOC Sciences
  26. 8.5.1 BOC Sciences Company Information
  27. 8.5.2 BOC Sciences Business Overview
  28. 8.5.3 BOC Sciences Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BOC Sciences Nystatin Product Portfolio
  30. 8.5.5 BOC Sciences Recent Developments
  31. 8.6 Fishfa Biogenics
  32. 8.6.1 Fishfa Biogenics Company Information
  33. 8.6.2 Fishfa Biogenics Business Overview
  34. 8.6.3 Fishfa Biogenics Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fishfa Biogenics Nystatin Product Portfolio
  36. 8.6.5 Fishfa Biogenics Recent Developments
  37. 8.7 HBCChem
  38. 8.7.1 HBCChem Company Information
  39. 8.7.2 HBCChem Business Overview
  40. 8.7.3 HBCChem Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 HBCChem Nystatin Product Portfolio
  42. 8.7.5 HBCChem Recent Developments
  43. 8.8 J & K SCIENTIFIC
  44. 8.8.1 J & K SCIENTIFIC Company Information
  45. 8.8.2 J & K SCIENTIFIC Business Overview
  46. 8.8.3 J & K SCIENTIFIC Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 J & K SCIENTIFIC Nystatin Product Portfolio
  48. 8.8.5 J & K SCIENTIFIC Recent Developments
  49. 8.9 LGM Pharma
  50. 8.9.1 LGM Pharma Company Information
  51. 8.9.2 LGM Pharma Business Overview
  52. 8.9.3 LGM Pharma Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LGM Pharma Nystatin Product Portfolio
  54. 8.9.5 LGM Pharma Recent Developments
  55. 8.10 Pure Chemistry Scientific
  56. 8.10.1 Pure Chemistry Scientific Company Information
  57. 8.10.2 Pure Chemistry Scientific Business Overview
  58. 8.10.3 Pure Chemistry Scientific Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pure Chemistry Scientific Nystatin Product Portfolio
  60. 8.10.5 Pure Chemistry Scientific Recent Developments
  61. 8.11 Toronto Research Chemicals
  62. 8.11.1 Toronto Research Chemicals Company Information
  63. 8.11.2 Toronto Research Chemicals Business Overview
  64. 8.11.3 Toronto Research Chemicals Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Toronto Research Chemicals Nystatin Product Portfolio
  66. 8.11.5 Toronto Research Chemicals Recent Developments
  67. 8.12 Waterstone Technology
  68. 8.12.1 Waterstone Technology Company Information
  69. 8.12.2 Waterstone Technology Business Overview
  70. 8.12.3 Waterstone Technology Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Waterstone Technology Nystatin Product Portfolio
  72. 8.12.5 Waterstone Technology Recent Developments
  73. 8.13 XiaoGan ShenYuan ChemPharm
  74. 8.13.1 XiaoGan ShenYuan ChemPharm Company Information
  75. 8.13.2 XiaoGan ShenYuan ChemPharm Business Overview
  76. 8.13.3 XiaoGan ShenYuan ChemPharm Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 XiaoGan ShenYuan ChemPharm Nystatin Product Portfolio
  78. 8.13.5 XiaoGan ShenYuan ChemPharm Recent Developments
  79. 8.14 Olon S.p.A
  80. 8.14.1 Olon S.p.A Company Information
  81. 8.14.2 Olon S.p.A Business Overview
  82. 8.14.3 Olon S.p.A Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Olon S.p.A Nystatin Product Portfolio
  84. 8.14.5 Olon S.p.A Recent Developments
  85. 8.15 Guangzhou Tosun Pharmaceutical
  86. 8.15.1 Guangzhou Tosun Pharmaceutical Company Information
  87. 8.15.2 Guangzhou Tosun Pharmaceutical Business Overview
  88. 8.15.3 Guangzhou Tosun Pharmaceutical Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guangzhou Tosun Pharmaceutical Nystatin Product Portfolio
  90. 8.15.5 Guangzhou Tosun Pharmaceutical Recent Developments
  91. 8.16 Pfizer
  92. 8.16.1 Pfizer Company Information
  93. 8.16.2 Pfizer Business Overview
  94. 8.16.3 Pfizer Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Pfizer Nystatin Product Portfolio
  96. 8.16.5 Pfizer Recent Developments
  97. 8.17 Concord Biotech
  98. 8.17.1 Concord Biotech Company Information
  99. 8.17.2 Concord Biotech Business Overview
  100. 8.17.3 Concord Biotech Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Concord Biotech Nystatin Product Portfolio
  102. 8.17.5 Concord Biotech Recent Developments
  103. 8.18 BrightGene Bio-Medical Technology
  104. 8.18.1 BrightGene Bio-Medical Technology Company Information
  105. 8.18.2 BrightGene Bio-Medical Technology Business Overview
  106. 8.18.3 BrightGene Bio-Medical Technology Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BrightGene Bio-Medical Technology Nystatin Product Portfolio
  108. 8.18.5 BrightGene Bio-Medical Technology Recent Developments
  109. 8.19 Antibiotice SA
  110. 8.19.1 Antibiotice SA Company Information
  111. 8.19.2 Antibiotice SA Business Overview
  112. 8.19.3 Antibiotice SA Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Antibiotice SA Nystatin Product Portfolio
  114. 8.19.5 Antibiotice SA Recent Developments
  115. 8.20 Shanghai Minbiotech
  116. 8.20.1 Shanghai Minbiotech Company Information
  117. 8.20.2 Shanghai Minbiotech Business Overview
  118. 8.20.3 Shanghai Minbiotech Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Shanghai Minbiotech Nystatin Product Portfolio
  120. 8.20.5 Shanghai Minbiotech Recent Developments
  121. 8.21 Zhejiang Huida Biotech
  122. 8.21.1 Zhejiang Huida Biotech Company Information
  123. 8.21.2 Zhejiang Huida Biotech Business Overview
  124. 8.21.3 Zhejiang Huida Biotech Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Zhejiang Huida Biotech Nystatin Product Portfolio
  126. 8.21.5 Zhejiang Huida Biotech Recent Developments
  127. 8.22 Centrient Pharmaceuticals
  128. 8.22.1 Centrient Pharmaceuticals Company Information
  129. 8.22.2 Centrient Pharmaceuticals Business Overview
  130. 8.22.3 Centrient Pharmaceuticals Nystatin Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Centrient Pharmaceuticals Nystatin Product Portfolio
  132. 8.22.5 Centrient Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nystatin Value Chain Analysis
  2. 9.1.1 Nystatin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nystatin Production Mode & Process
  6. 9.2 Nystatin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nystatin Distributors
  9. 9.2.3 Nystatin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst